Menu
ncarol.com
  • Home
  • Music
  • Books
  • Manufacturing
  • Book Release
  • Asheville Music
  • Health
  • Business
  • Real Estate
ncarol.com

Labratfinder.com launches the COVID-19 web research info center as "Who is Who, Where is Who, and Who Uses What Products" free to access web page
ncarol.com/10054021

Trending...
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
Zoom-in view of the map widget on Labratfinder.com View of the map widget in Labratfinder.com VIew on the entire Labratfinder.com COVID19 widget Labratfinder LLC
Labratfinder.com is bringing the latest in COVID-19 research, in the form of the "Who is Who, Where is Who and Who Uses What Products" page. Based on the Artificial Intelligence analysis of millions of published peer-reviewed publications, Labratfinder.com presents the summarized reports of: researchers, research publications, products, brands used in COVID-19 research and geographical distribution of research institutions.

SILVERADO, Calif. - ncarol.com -- Labratfinder.com is a novel artificial intelligence based system for discovering the true end users of scientific products, key opinion leaders and prospecting collaborators. This free resource is aimed to help researches and other parties of interest across the globe involved in COVID-19 research to find the latest published information and identify potential collaborators, research products, and appropriate research techniques.

Their "Who Is Who, Where is Who and Who uses What in a World of COVID-19" resource page is based on the Artificial Intelligence analysis of millions of published peer-reviewed publications for a specific combination of keywords. On this page, one can see:

More on ncarol.com
  • Google AI Says KayeDinero Isn't the Greatest Female Producer. She Asks: Who Decides?
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
  • From Michael Jackson to Drake: The Artists Who Shaped KayeDinero's Sound
  • L-Tron to Attend the 2026 NC, GA, TN, SC Joint Regional IAI Conference

  • Organizations and scientists involved on an interactive map;
  • Browse through the list or researchers with contact info and all relevant publications;
  • Find out which major brands of life science research products are used in COVID-19 research; and how they are used by reading the references;
  • And find how a particular research or laboratory / analytical techniques was used in the COVID-19 research.
The results are provided in an easy to search, exportable tables, ranked by: dates; number of publications; number of citations; and in a graphical interactive form representing the geographic distribution of information in a map based infographics.

This free, daily updated "Who is Who, Where is Who and Who Uses What in a World of COVID-19 Research page" can be readily accessed by clicking on this web page link: http://www.labratfinder.com/covid-19.

Media Contact
Prof. Miodrag "Mickey" Micic, Sc.D.,Ph.D.,, M.T.M.
President / CEO
mm@labratfinder.com
9499811068


Source: Labratfinder LLC
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Who Is KayeDinero? The Asheville Artist Also Builds Software and Trading Systems
  • Leaping Cat Creative Takes Shape Around the Problems Nobody Quite Owns
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
  • As Boone Takes Art to the Streets, KayeDinero Asks What Makes Creativity Human
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Black Mountain Meets "Human Error": KayeDinero on What Technology Can't Reproduce
  • As Brevard Heads Into Mountain Song Weekend, KayeDinero Brings a Different Kind of WNC Sound
  • Why Did KayeDinero Put Haywood Road Into a Song?
  • Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
  • TekTone innovation meets patient care
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
  • P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
  • DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
  • Crawler Record for WordPress Version 1.0
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 156
  • Parksy (parksy.com) Tackles the Most Common Parking Problem Nobody Talks About: Finding the Car Again - 154
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 144
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 138
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate - 132
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 123
  • BumbleBeeSmart Launches Dedicated Sensory Wall Panels Collection for Adults, Memory Care and Senior Living - 121
  • From Temecula Wine Country to Canyon Lake: Parkway Construction Transforms Outdoor Spaces for Inland Homeowners - 121
  • Bspin Launches Lightning-Fast Crypto Gaming Expansion With Sportsbook, Poker, VIP Rewards, and Bitcoin Lightning Network Integration - 121
  • Project CIVICA Report Finds 10,680 Non-Citizen Indicators on New York Voter Rolls — Including 88 Records with Recent Voting History - 119

Similar on ncarol.com

  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • White Coat Financial Partners Announces Launch of Next Generation Practice Optimization Software
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Piedmont Crossing Celebrates 40 Years of Caring, Community, and Connection
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute